HIMSSCast: Medically Home funding is a big investment in hospital acute care
Mayo Clinic is able to send kidney and marrow transplant patients home to recover to a hospital level of care, says Medically Home CEO Rami Karjian.
Acute-level care at home is another innovation driven by the pandemic, though the concept is not new. As hospitals needed to free up beds and CMS loosened restrictions, health systems set up programs and invested in partnerships that could help.
Medically Home offers the logistics, hardware and software technology to make it possible for care providers to give the same acute level of care at home that they would have in the hospital, says CEO Rami Karjian, who spoke to Healthcare Finance News Executive Editor Susan Morse. The result has been good for both providers and patients.
Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Play!
Talking Points:
- Kaiser Permanente and Mayo Clinic are providing hospital-level care at home through Medically Home.
- Patients getting kidney and bone marrow transplants at Mayo are recovering at home.
- Kaiser and Mayo invested $100 million in Medically Home in May 2021.
- Other strategic partners such as Global Medical Response have added $110 million.
- Medically Home provides the technology and logistics to scale about 20% of what is done in brick-and-mortar hospitals.
- The hospital at home model is not new, but interest has risen during the pandemic.
- This has been spurred by CMS flexibilities during the PHE.
- A coalition of over 25 health systems have asked CMS to continue the flexibilities.
- Payers and providers in value-based care contracts need not worry about Medicare FFS incentives.
More about this episode:
Mayo Clinic announces advanced care at home model with Medically Home
Mayo Clinic, Kaiser put $100M toward hospital-at-home care
The rise of hospital at home care
Healthcare groups urge Congress to extend Acute Hospital Care at Home waiver
